RESEARCH, TRADITIONS AND SAFETY

Male fertility & sperm health

Some foods and herbs have small studies of sperm measurements, but a better semen result does not guarantee conception. Several larger supplement trials have not improved pregnancy or birth outcomes. These records compare the evidence rather than rank remedies.

Semen quality, male-factor infertility and reproductive outcomes. Sperm concentration, motility, morphology and DNA measures are distinct from pregnancy and live birth. Testicular emergencies and cancer care remain separate.

An ivory reference book and small dish holding three symbolic seeds
Decorative topic illustration.

Care basics come first

How we chose these entries

Selected food, herb, nutrient and combination studies include limited positive findings, important no-benefit results, historical context and a clearly separated laboratory reference.

Evidence does not establish a general fertility supplement regimen. Most small positive studies measure semen rather than pregnancy or live birth. Results do not establish cancer prevention, treatment of torsion, healthy-testis protection or universal testosterone enhancement.

13 reviewed records

Care and risk-reduction research

Read the outcome, preparation and limits. A studied benefit does not make every product effective.

Support during care

Black seed oil

Engraved Nigella sativa seed capsule with angular black seeds and oil vessel.
Ingredient reference illustration: Black seed oil. Studied form: Cold-pressed seed oil. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Nigella sativa L. · Seed fixed oil

Form
Cold-pressed seed oil
How it is used
oral
Evidence
Limited clinical evidence

One small placebo-controlled trial reported better sperm concentration, motility and morphology. Pregnancy and live-birth benefit was not established.

Condition and setting

Abnormal semen quality in men with infertility

Cautions

  • Study exposure is not a personal dose recommendation. Severe dermatitis has followed topical oil use; the drug-metabolism signal came from oral seed in four volunteers, not a test of every oil product. Ask a pharmacist to review medicines.

Read full ingredient card: Black seed oil

Evidence, limits and sources for Black seed oil

What was found

Two months; 34 analyzed per arm; 2.5 mL twice daily versus liquid paraffin.

What this does not show

Short trial in selected infertile men; does not show healthy-testis protection or treatment of testicular disease. Essential oil and isolated thymoquinone are different.

Exact ingredient

The trial concerns expressed fixed seed oil; whole seed, essential oil and isolated thymoquinone are different materials.

Why we included it

Direct human semen research distinct from cancer claims.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Support during care

Black cumin seed

Engraved Nigella sativa seed capsule with angular black seeds and oil vessel.
Ingredient reference illustration: Black cumin seed (KJV fitches candidate). Studied form: Seed-powder capsules; separate traditional-use context. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Nigella sativa L. · Seed

Form
Seed-powder capsules; separate traditional-use context
How it is used
oral
Evidence
Very low-certainty clinical evidence

A weak study reported semen and hormone changes. These findings do not establish a testosterone booster or an infertility treatment.

Condition and setting

Male infertility and reproductive-hormone research

Cautions

  • Medicinal supplementation differs from a culinary serving. No proven pregnancy/live-birth benefit; do not postpone evaluation.

Read full ingredient card: Black cumin seed (KJV fitches candidate)

Evidence, limits and sources for Black cumin seed

What was found

Reported 2 g/day for three months; 55 enrolled, 40 completed. A separate traditional database records an ejaculation-related use.

What this does not show

Placebo allocation/sample sizes and analysis are unclear. A separate obesity study found no significant free-testosterone advantage; traditional terms do not establish modern diagnoses.

Exact ingredient

The evidence concerns oral seed powder; the pressed fixed oil has separate evidence.

Why we included it

Separates whole-seed evidence and tradition from pressed oil.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Support during care

Walnuts (Persian / English)

Engraved study of Walnut oil. Source-plant study: Walnut oil
Ingredient reference illustration: Walnuts (Persian / English). Studied form: Whole shelled walnuts added to usual diet. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Juglans regia L. · Edible kernel

Form
Whole shelled walnuts added to usual diet
How it is used
oral food
Evidence
Limited dietary trial evidence

Sperm vitality, motility and morphology improved in a dietary trial. This is not evidence of more pregnancies or live births.

Condition and setting

Semen quality in healthy young men eating a Western-style diet

Cautions

  • Avoid with walnut allergy. Account for the substantial food energy and overall diet; the study portion is not a required fertility prescription.

Read full ingredient card: Walnuts (Persian / English)

Evidence, limits and sources for Walnuts (Persian / English)

What was found

Randomized trial with masked outcome assessors; 117 men aged 21–35; 75 g/day for 12 weeks versus usual diet avoiding tree nuts.

What this does not show

Healthy men rather than an infertility-treatment population; whole nuts do not establish walnut-oil effects. Food trial could not blind participants.

Exact ingredient

The evidence concerns edible English/Persian walnut kernels, not black-walnut hulls or extracted walnut oil.

Why we included it

A whole-food trial provides context beyond supplements.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Support during care

Date-palm pollen and black-seed combination

Supportive-care research reference symbol; no product shown
Supportive-care research reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Phoenix dactylifera L.; Nigella sativa L. · Date-palm pollen and black seed preparation

Form
Studied combination capsules plus standard infertility treatment
How it is used
oral
Evidence
Very low-certainty combination evidence

The small combination trial reported sperm and hormone changes, but it cannot identify black seed’s contribution.

Condition and setting

Male infertility; semen and hormone measures

Cautions

  • Do not recreate the reported capsule regimen or substitute retail oil. Check allergy history and every product ingredient with the care team.

Why no exact ingredient link?

This is a combined date-palm pollen and black-seed preparation with inconsistent ingredient descriptions; neither ingredient alone represents it.

Evidence, limits and sources for Date-palm pollen and black-seed combination

What was found

Single-blind study, 50 analyzed over three months.

What this does not show

Dose and preparation descriptions conflict, including seed versus pollen terminology. No demonstrated live-birth benefit.

Exact ingredient

This is a combined date-palm pollen and black-seed preparation with inconsistent ingredient descriptions; neither ingredient alone represents it.

Why we included it

Keeps a mixed traditional preparation separate from single-herb claims.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Support during care

Ashwagandha root

Ashwagandha root showing root.
Ingredient reference illustration: Ashwagandha root. Studied form: KSM-66 root extract standardized to at least 5% withanolides. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Withania somnifera (L.) Dunal · Root

Form
KSM-66 root extract standardized to at least 5% withanolides
How it is used
oral
Evidence
Limited pilot-trial evidence

A small pilot trial reported improved sperm concentration, motility and semen volume. It did not establish a pregnancy or live-birth benefit.

Condition and setting

Oligospermia in men with infertility

Cautions

  • Drowsiness and digestive upset can occur; liver injury has been reported. Discuss liver or thyroid disease and medicines with a clinician. Long-term safety is uncertain. Avoid with hormone-sensitive prostate cancer.

Read full ingredient card: Ashwagandha root

Evidence, limits and sources for Ashwagandha root

What was found

Double-blind placebo-controlled trial; 46 men; 675 mg/day of the specified root extract for 90 days.

What this does not show

Exploratory sample without a power calculation. Widely quoted percentage improvements compare the treated group with its own baseline, not with placebo. Findings cannot establish a general fertility or testosterone treatment.

Exact ingredient

The evidence concerns a standardized root-only extract; raw root powder and root-leaf extracts are different preparations.

Why we included it

A directly studied root preparation with preliminary semen findings and important safety limits.

Sources

Support during care

Maca

Watercolor of dried yellow, red and dark maca roots beside beige flour.
Ingredient reference illustration: Maca. Studied form: Gelatinized maca powder in capsules; yellow maca specified in the 2021 trial. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Lepidium meyenii Walp. · Dried underground hypocotyl/root, described as bulb in the yellow-maca trial

Form
Gelatinized maca powder in capsules; yellow maca specified in the 2021 trial
How it is used
oral
Evidence
Mixed, low-certainty clinical evidence

Small placebo-controlled trials give mixed results. One found higher sperm concentration; another did not establish a semen benefit. Improved pregnancy or live birth is unproven.

Condition and setting

Semen quality in men with infertility

Cautions

  • One trial reported no adverse effects; the other had two withdrawals for possible adverse events, with causality uncertain. Small trials cannot establish long-term safety.

Read full ingredient card: Maca

Evidence, limits and sources for Maca

What was found

2020: 69 men randomized, 2 g/day for 12 weeks. 2021: 50 randomized, yellow maca 2.8 g/day for 16 weeks.

What this does not show

Small samples, short follow-up and attrition. The positive trial found no benefit in motility, morphology or volume. Four incidental partner pregnancies in the other trial do not establish efficacy.

Exact ingredient

The tested gelatinized powders are not interchangeable with concentrated extracts or an assumed black-maca formulation.

Why we included it

Contrasting randomized results counter a simple fertility-enhancement claim.

Sources

Support during care

Omega-3 EPA and DHA preparations

Engraved source or material study: a flax flower stem and a few flax seeds beside a small unlabelled oil cruet.
Ingredient reference illustration: Omega fatty acid oils. Studied form: Specified EPA/DHA oils, including EPAX 5500TG and DHA-enriched fish triglyceride oil. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Eicosapentaenoic acid and docosahexaenoic acid

Form
Specified EPA/DHA oils, including EPAX 5500TG and DHA-enriched fish triglyceride oil
How it is used
oral
Evidence
Mixed surrogate-outcome evidence

Trials give mixed sperm-marker results. An EPA/DHA trial reported improved count and concentration; another improved DNA-fragmentation measures without conventional semen benefits. Pregnancy and live-birth benefit is unproven.

Condition and setting

Semen quality and sperm DNA measures in fertility-clinic populations

Cautions

  • Fish-oil preparations may cause unpleasant taste, bad breath, heartburn or digestive upset. Discuss anticoagulants and other medicines with a clinician before supplementation.

Read full ingredient card: Omega fatty acid oils

Evidence, limits and sources for Omega-3 EPA and DHA preparations

What was found

2011: 238 randomized, 211 completed; EPA+DHA 1.84 g/day for 32 weeks. 2016: 74 randomized, 57 analyzed; DHA 990 mg plus EPA 135 mg/day for ten weeks.

What this does not show

Different formulations, attrition and surrogate outcomes limit confidence. The 2011 abstract reports baseline-to-end changes rather than a complete placebo-adjusted estimate. These trials do not test an omega-3/6/9 blend.

Exact ingredient

The findings apply to the specified EPA/DHA oils, not to omega-6/9 blends or assumed equivalent effects of plant ALA.

Why we included it

Distinguishes exact EPA/DHA trial preparations from broader fatty-acid marketing.

Sources

Tradition and early research

These historical reports or laboratory findings do not establish a clinical benefit.

Early lab research

Black-seed aqueous extract: laboratory sperm research

Early lab research symbol; no product shown
Early lab research. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Nigella sativa L. · Seed

Form
Aqueous extract added to cryopreservation medium
How it is used
ex vivo laboratory use
Evidence
Human-sample laboratory evidence

A laboratory experiment reported improvements in selected post-thaw sperm measures. This was not a trial of men swallowing a supplement.

Condition and setting

Human sperm specimens during freezing/thawing

Cautions

  • Never add household extracts or oils to semen, fertility-treatment media or the genitals based on this experiment.

Why no exact ingredient link?

This aqueous seed extract was added to a laboratory sperm medium; it is not an oral seed or fixed-oil preparation.

Evidence, limits and sources for Black-seed aqueous extract: laboratory sperm research

What was found

Twenty sperm samples tested under controlled vitrification conditions.

What this does not show

No demonstrated conception or birth benefit; laboratory concentration and route cannot be translated into oral or genital use.

Exact ingredient

This aqueous seed extract was added to a laboratory sperm medium; it is not an oral seed or fixed-oil preparation.

Why we included it

Makes the human-sample versus treated-human distinction explicit.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Safety and no-benefit findings

These records explain what to avoid or why a proposed benefit is not established.

No benefit or possible harm

Saffron extract: unresolved plant-part reporting

No-benefit evidence reference symbol; no product shown
No-benefit evidence reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Crocus sativus L. · Reported as stigma, but extraction description says petal

Form
Studied ethanol-extract capsules; plant-part description inconsistent
How it is used
oral
Evidence
Negative randomized trial

Saffron did not significantly improve sperm density, motility, morphology or seminal antioxidant capacity versus placebo.

Condition and setting

Idiopathic oligoasthenoteratozoospermia

Cautions

  • Four saffron recipients stopped because of adverse events, including nausea, headache, increased appetite and hypomania. Do not increase the dose to overcome a negative result.

Why no exact ingredient link?

The trial methods conflict between stigma and petal extraction, so its material cannot be equated confidently with culinary saffron stigma.

Evidence, limits and sources for Saffron extract: unresolved plant-part reporting

What was found

260 infertile men randomized to 60 mg/day or placebo for 26 weeks.

What this does not show

The methods call purchased material stigma but describe extracting petal. Exact identity is unresolved; do not silently equate this preparation with culinary stigma or crocin.

Exact ingredient

The trial methods conflict between stigma and petal extraction, so its material cannot be equated confidently with culinary saffron stigma.

Why we included it

A meaningful negative result for a traditionally promoted herb.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

No benefit or possible harm

MOXI antioxidant combination

No-benefit evidence reference symbol; no product shown
No-benefit evidence reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Vitamins, minerals, L-carnitine and lycopene

Form
Studied oral antioxidant combination including vitamins C, E and D, selenium, L-carnitine, zinc, folic acid and lycopene
How it is used
oral
Evidence
Negative multicenter randomized pilot

No improvement in semen quality or DNA integrity was established. Live births were 15% versus 24% with placebo, without a significant difference.

Condition and setting

Male-factor infertility; semen and live-birth outcomes

Cautions

  • Avoid stacking overlapping fertility vitamins. More antioxidants are not automatically better.

Why no exact ingredient link?

This is a multi-ingredient antioxidant formulation; its results cannot be assigned separately to its individual nutrients.

Evidence, limits and sources for MOXI antioxidant combination

What was found

171 participants received assigned supplement/placebo for 3–6 months; couples also had a defined fertility-care pathway.

What this does not show

Early stopping left pregnancy/live-birth analyses underpowered. The lower numerical birth rate is not proof of harm; a blend cannot settle each ingredient’s effects.

Exact ingredient

This is a multi-ingredient antioxidant formulation; its results cannot be assigned separately to its individual nutrients.

Why we included it

Connects laboratory claims with measured birth outcomes.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

No benefit or possible harm

SUMMER antioxidant combination (Impryl)

No-benefit evidence reference symbol; no product shown
No-benefit evidence reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Betaine, L-cystine, B vitamins and zinc

Form
Studied Impryl tablet
How it is used
oral
Evidence
Large negative randomized trial

Ongoing pregnancy within six months was not improved: 33.8% versus 37.5% with placebo. This article did not yet report live-birth results.

Condition and setting

Men seeking fertility care; ongoing-pregnancy outcome

Cautions

  • Reported adverse events were uncommon and similar, including digestive discomfort, fatigue and headache. Routine use was not supported.

Why no exact ingredient link?

This is the tested Impryl combination; individual nutrients and other antioxidant blends are not equivalent treatments.

Evidence, limits and sources for SUMMER antioxidant combination (Impryl)

What was found

2025 multicenter double-blind trial; 1,171 men analyzed, daily combination for six months alongside standard care.

What this does not show

Only 58% adequately adhered. A prespecified 4–6-month analysis found lower ongoing pregnancy with the supplement, which is concerning but not a universal all-antioxidant harm estimate.

Exact ingredient

This is the tested Impryl combination; individual nutrients and other antioxidant blends are not equivalent treatments.

Why we included it

A recent large trial measured pregnancy rather than only sperm markers.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

No benefit or possible harm

Folic acid and zinc combination

No-benefit evidence reference symbol; no product shown
No-benefit evidence reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Folic acid and elemental zinc

Form
Quality-controlled combination tablet; zinc salt not specified in the main report
How it is used
oral
Evidence
Large negative randomized trial

A large trial found no improvement in live birth or conventional semen measures. Live birth occurred in 34% of the supplement group and 35% of the placebo group.

Condition and setting

Couples undergoing infertility treatment; semen quality and live birth

Cautions

  • Digestive symptoms were more frequent, and sperm DNA fragmentation was slightly higher, although its clinical importance is uncertain. Avoid overlapping supplements; excessive zinc can cause copper deficiency.

Why no exact ingredient link?

A combination-tablet result cannot be assigned to folate or zinc as an individual treatment.

Evidence, limits and sources for Folic acid and zinc combination

What was found

FAZST: 2,370 couples; male partners took folic acid 5 mg plus elemental zinc 30 mg daily, or placebo, for six months.

What this does not show

Broad infertility-care population; six-month semen samples missing for 31%. Findings concern the combination and do not resolve treatment of a diagnosed deficiency or either nutrient alone.

Exact ingredient

This study tested the two nutrients together; neither ingredient alone represents the studied treatment.

Why we included it

Direct live-birth evidence from a large, blinded trial is more informative than semen-marker claims alone.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

No benefit or possible harm

Selenium

Engraved source or material study: three Brazil nuts with one opened shell.
Ingredient reference illustration: Selenium. Studied form: High-selenium yeast in the 2009 trial; selenomethionine in the older low-selenium study. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Selenium in specified supplement formulations

Form
High-selenium yeast in the 2009 trial; selenomethionine in the older low-selenium study
How it is used
oral
Evidence
Mixed and population-dependent trial evidence

Routine selenium supplementation is not supported for improving sperm quality. A small low-selenium study suggested benefit, but a longer trial in healthy men found none.

Condition and setting

Semen quality in healthy men and subfertile men with low selenium status

Cautions

  • Excess selenium can cause hair and nail loss, digestive symptoms and neurological problems. Correcting a diagnosed deficiency differs from routinely taking a high-dose fertility supplement.

Read full ingredient card: Selenium

Evidence, limits and sources for Selenium

What was found

2009: 54 randomized, 42 completed; selenium yeast 300 micrograms/day for 48 weeks, with no sperm benefit. 1998: 69 men with low selenium status; three-month trial.

What this does not show

The older motility result became significant only after pooling two selenium arms; five paternity events are too few for a firm fertility conclusion. A separate widely cited selenium/NAC trial has an Expression of Concern.

Exact ingredient

The studies used different selenium formulations and populations; high-selenium yeast and selenomethionine results are not automatically equivalent.

Why we included it

Separates nutrient sufficiency from unproven routine supplementation and preserves the important null result.

Sources